Search result

Scottish Seedcorn Fund for Neurological Research open for applications

The Chief Scientist Office and the RS Macdonald Charitable Trust have provided funds for ‘seedcorn grants’, administered by the University of St Andrews, to enable researchers to test innovative ideas related to neurodegenerative or neurodevelopmental conditions The collaboration is keen to award funding across three gene...

View Page

Precision Medicine Alliance Scotland funding call

The Chief Scientist Office (CSO) is today launching a call to stimulate delivery of Precision Medicine in NHS Scotland We are looking to fund specific programmes of work that will tackle health conditions of major importance in Scotland. This includes diseases that disproportionately impact those at risk of socioeconomic disadvantage. Applications can be up to £750,000 per annum (80% Full Economic...

View Page

Public underestimate UK’s role in coronavirus research, survey reveals

A significant disconnect exists between people’s perceptions of the importance of coronavirus research, and their understanding of where it happened and who took part, according to a survey commissioned to mark International Clinical Trials Day The YouGov survey, published today, asked 2,023 respondents a range of questions on their understanding of coronavirus research - especially research in the UK - and the role it has played in tackling the pandemic.  Public p...

View Page

World first COVID-19 vaccine booster study launches in NHS Greater Glasgow and Clyde

Volunteers from NHS Greater Glasgow and Clyde will soon be able to receive a third ‘booster’ COVID-19 vaccine through a new clinical trial launching this week The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at Glasgow Clinical Research Facilities – one of 16 sites across the UK. It will be the first in the world to provid...

View Page

Vacancy: NRS Renal Clinical Lead

The Chief Scientist Office is looking to appoint a clinical lead for NRS Renal Hours: 0.1FTE/ 1 PA per week Length: 3 years initially, with the possibility to extend Salary: Pro-rata within the post holder’s pay s...

View Page

Vacancy: NRS Musculoskeletal Clinical Lead

The Chief Scientist Office is looking to appoint a clinical lead for NRS Musculoskeletal Hours: 0.2FTE/ 2 PAs per week Length: 3 years initially, with the possibility to extend Salary: Pro-rata within t...

View Page

First COVID-19 vaccine study for pregnant women launches in the UK

The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched and will be open in NHS Lothian The phase 2/3 study aims to further understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in healthy pregnant women, with approximately 235 volunteers involved throughout the UK. Following

View Page

Volunteers needed across NHS Greater Glasgow and Clyde and NHS Lothian for latest COVID-19 vaccine study

The latest vaccine study to open in the UK examining a new COVID-19 vaccine candidate is recruiting volunteers across Greater Glasgow and Clyde and Lothian Developed by the specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian, and is the only inactivated, adjuvanted (an ingredient to create a stronger immune response) COVID-19 vaccine in clinical development in Europe. Inactivated vaccines are a well-established...

View Page

Latest COVID-19 vaccine study launches in NHS Grampian

The latest COVID-19 vaccine study in the UK has opened in Scotland in NHS Grampian Medicago, a biopharmaceutical company based in Canada, and GlaxoSmithKline (GSK) are launching the Phase 3 randomised, observer blinded, placebo-controlled study. The study supported in the UK by the National Institute for Health Research (NIHR), NHS Research Scotland (NRS) and Health and Care Research Wales is the first to test a plant-derived COVID-19 vaccine candidate, and will evaluate the efficacy...

View Page

Key changes to UK amendment process

The devolved administrations, the HRA and the MHRA have agreed to make two key changes to the UK amendment process with effect from 25 March 2021 Firstly, the addition of a new NHS/HSC site or a change of PI at an NHS/HSC site for a CTIMP study will now be classified as a Non-Substantial Amendment*. This was previously considered a Substantial Amendment. The change is designed to speed up new site set up. This is possible because new sites were categorised as substantial due to EU gu...

View Page